(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTOS ANTAGONISTAS DE H4

ArquivadaInvention PatentPCT · GB2021050971

Application data

Number

112022021395

Type

Invention Patent

Filing

04/22/2021

Publication

12/13/2022

PCT

GB2021050971

Progress at the INPI

  1. Filing04/22/21
  2. Publication12/13/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/23/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

HEPTARES THERAPEUTICS LIMITED

GB

NXERA PHARMA UK LIMITED

GB

See this company's full portfolio

Inventors

C. F. (pessoa física)

GB

D. H. (pessoa física)

GB

M. P. (pessoa física)

GB

M. C. (pessoa física)

GB

N. S. (pessoa física)

GB

Technical data

Priority claims

GB

2005858.2 · 04/22/2020

Abstract

COMPOSTOS ANTAGONISTAS DE H4. A presente invenção refere-se a derivados de azetidinilpirimidin-2-amina, seu uso como antagonistas do receptor de histamina H4 e seu uso no tratamento, prevenção, melhora, controle ou redução do risco de distúrbios associados aos receptores H4.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

12/23/2025

RPI 2868

Parecer de pré-exame

#6.23

09/09/2025

RPI 2853

Alteração de nome deferida

#25.4

04/01/2025

RPI 2830

Notificação de entrada na fase nacional - PCT

#1.3

12/13/2022

RPI 2710

Alteração de dados cadastrais

#1.1

11/01/2022

RPI 2704

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.